Targeted and effective glioblastoma therapy via aptamer-modified tetrahedral framework nucleic acid-paclitaxel nanoconjugates that can pass the blood brain barrier | |
Shi S.[1]; Fu W.[2]; Lin S.[1]; Tian T.[1]; Li S.[1]; Shao X.[1]; Zhang Y.[1]; Zhang T.[1]; Tang Z.[3]; Zhou Y.[4] | |
2019 | |
卷号 | 21 |
URL标识 | 查看原文 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4701392 |
专题 | 成都中医药大学 |
作者单位 | 1.[1]State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, China 2.[2]Department of Neurosurgery, West China Hospital of Sichuan University, Chengdu, China 3.[3]Department of Endodontics, Shanghai Ninth People's Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine, Shanghai, China 4.[4]College of Basic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, China |
推荐引用方式 GB/T 7714 | Shi S.[1],Fu W.[2],Lin S.[1],et al. Targeted and effective glioblastoma therapy via aptamer-modified tetrahedral framework nucleic acid-paclitaxel nanoconjugates that can pass the blood brain barrier[J],2019,21. |
APA | Shi S.[1].,Fu W.[2].,Lin S.[1].,Tian T.[1].,Li S.[1].,...&Cai X.[1].(2019).Targeted and effective glioblastoma therapy via aptamer-modified tetrahedral framework nucleic acid-paclitaxel nanoconjugates that can pass the blood brain barrier.,21. |
MLA | Shi S.[1],et al."Targeted and effective glioblastoma therapy via aptamer-modified tetrahedral framework nucleic acid-paclitaxel nanoconjugates that can pass the blood brain barrier".21(2019). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论